Colloid or crystalloid for goal directed fluid therapy in patients undergoing elective colorectal surgery
- Conditions
- Elective surgical resection of the colonDigestive System
- Registration Number
- ISRCTN41882213
- Lead Sponsor
- York Hospitals NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 202
Patients (both males and females) over 55 years of age undergoing elective colorectal surgery, who after routine cardiopulmonar exercise testing (CPET) at the Pre-assessment Clinic, have been found to have an oxygen uptake at anaerobic threshold (AT) less than or equal to 14.0 ml/kg/min as measured by the V-slope method.
1. Patients less than 55 years of age
2. Patients having emergency procedures
3. Those who are American Society of Anaesthesiologists (ASA) classification grade 5
4. Patients who refuse or are unable to give informed consent
5. Renal failure with oliguria or anuria not related to hypovolaemia
6. Patients receiving dialysis treatment
7. Intracranial bleeding
8. Known hypersensitivity to hydroxyethyl starches or gelatins
9. Patients with sodium overload
10. Patients who have had inadequate time (less than 24 hours) to consider the Patient Information Leaflet
11. Patients with hypertrophic obstructive cardiomyopathy (HOCM), aortic stenosis, phaeochromocytoma, a low platelet count, or have used a monoamine oxidase inhibitor within the last 14 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of gastrointestinal morbidity on day 5 following surgery.
- Secondary Outcome Measures
Name Time Method 1. Incidence of post operative complications during hospital stay<br>2. Morbidity at 1, 3, 5, 8, 10 days measured by Postoperative Morbidity Survey<br>3. Length of stay in hospital after surgery<br>4. Recovery parameters (time to eating, drinking, and mobilising after surgery)<br>5. Peri-operative haemodynamic variables (central venous pressure [CVP], heart rate, blood pressure, oxygen delivery, stroke volume variation)<br>6. Cost effectiveness of the intervention<br>7. Measurement of inflammatory markers<br>8. Use of additional inotropic support<br>9. Use of rescue colloid boluses